Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ANKHD1-EIF4EBP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CHFR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARFGAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MFSD5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLCL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAFAH1B3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SFT2D3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
RNF34 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC39A3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KCTD10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TADA3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
INSR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANAPC15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPS12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SARS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ECHS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on